Analyst Upgrades

• Piper Jaffray upgraded Psychiatric Solutions (PSYS) to neutral from underweight on expectations the company's merger with Universal Health (UHS) will close.
• Jefferies upgraded Intuit (INTU) to buy from neutral and has a $45 price target on the stock. The firm expects Intuit's 2011 tax season to be at least as good as 2010's and sees improvement in the SMB exposed businesses.
• Wells Fargo upgraded Unica (UNCA) to outperform from market perform. The firm upgraded the stock due to what it sees as improving trends in marketing spending, upcoming enhancements in the company's products and long-term opportunity for marketing software to exceed expectations.
• Textron (TXT) was upgraded to conviction buy from buy at Goldman.
• RightNow (RNOW) was upgraded to outperform from market perform at FBR Capital.
• Beazer Homes (BZH) was upgraded to buy from hold at Citigroup.

Analyst Upgrades

• JMP Securities upgraded Boston Properties (BXP) to outperform from market perform and has an $89 price target on the stock. The firm upgraded shares based on near-term catalysts that include, the potential start of 1msf of development in Midtown, investments, and selection as 1 World Trade Center project manager.
• Baird upgraded Bucyrus (BUCY) to outperform from neutral, citing valuation and an a more favorable view of the Terex Mining acquisition. The firm has an $83 price target on the stock.
• Jefferies upgraded Warner Chilcott (WCRX) to buy from hold and has a $30 price target on the stock. The firm upgraded shares based on valuation and conservative guidance.
• AmeriCredit (ACF) was upgraded to market perform from underperform at Keefe Bruyette.
• Royal Dutch Shell (RDS.A) was upgraded to overweight from neutral at JPMorgan.
• Rio Tinto (RTP) was upgraded to outperform from market perform at Bernstein.

United States Oil Fund (USO) was recently down 38 cents to $34.43 in pre-open trading. WTI Crude futures were recently down 0.53% to $71.23, according to Bloomberg. USO unit net asset value reflects the performance of the spot price of West Texas intermediate light crude. USO overall option implied volatility of 36 is near its 26-week average of 35 according to Track Data, suggesting non-directional price movement.

Stocks with implied volatility above 30-day mean: Psychiatric Solutions (PSYS), Agnico-Eagle Mines (AEM), Moody's (MCO), Monsanto (MON), Wal-Mart (WMT) according to IVolatility.

Update is by Stock Specialist Paul Foster of theflyonthewall.com

U.S. stock futures reversed direction from earlier declines and inched higher Monday following several deal news. Still, worries over European sovereign debt persisted, as well as concerns over China economy. The euro fell to four-year lows against the dollar and Shanghai Composite tumbled 5%.

Asian shares slumped as investors feared that European austerity measures will threaten global economic growth. Other than the 5% plunge of China's Shanghai Composite, Japan's Nikkei 225 tumbled 2.2% and Hong Kong's Hang Seng fell 2.1%.

Analyst Upgrades

• Wells Fargo upgraded Universal Health (UHS) to outperform from market perform to reflect the company's potential acquisition of Psychiatric Solutions (PSYS). The firm sees a 60% chance of Universal Health acquiring Psychiatric Solutions and estimates the deal would be accretive.
• Oppenheimer upgraded Lamar Advertising (LAMR) to outperform from perform following the company's Q1 results and Q2 guidance as it expects growth to pick up in Q3. The firm has a $44 price target for shares.
• UBS upgraded Las Vegas Sands (LVS) to buy from neutral based on valuation and Singapore outlook. The firm raised its price target to $28 from $24.
• Priceline.com (PCLN) was upgraded to buy from hold at ThinkEquity.
• Alcoa (AA) Was upgraded to outperform from market perform at BMO Capital.
• Brookfield Asset Management (BAM) was upgraded to outperform from neutral at Credit Suisse.

Analyst Upgrades

• FBR Capital upgraded Digital River (DRIV) to outperform from market perform on expectations the company's business activity is improving. The firm raised its price target for shares to $36 from $25.
• Cowen upgraded Carpenter Technology (CRS) to outperform from neutral, citing expectations for a restocking turnaround for the upgrade.
• Och-Ziff Capital (OZM) was upgraded to outperform from market perform at William Blair.
• Wellpoint (WLP) was upgraded to outperform from market perform at BMO Capital.
• Kohlberg Capital (KCAP) was upgraded to hold from sell at Stifel Nicolaus.

Analyst Upgrades

• UBS upgraded Starbucks (SBUX) to buy from neutral, citing expectations for sales momentum. The firm raised its price target to $29 from $27.
• Piper Jaffray upgraded Sonic (SONC) two notches to overweight from underweight on expectations the company's sales and margin trends are set to improve. The firm raised its target price for shares to $12 from $8.
• BMO Capital upgraded Chicago Bridge & Iron (CBI) to outperform from market perform, citing its outlook for earnings growth. The firm has a $30 target on the stock.
• Clorox (CLX) was upgraded to overweight from equal weight at Barclays.
• Alexion Pharma (ALXN) was upgraded to conviction buy from buy at Goldman.
• Compellent (CML) was upgraded to buy from hold at ThinkEquity.

Analyst Upgrades

• UBS upgraded Dr Pepper Snapple (DPS) to buy from neutral, citing strong fundamentals and buybacks. The firm raised its target to $42 from $31.
• Piper Jaffray upgraded ProAssurance (PRA) to overweight from neutral. The firm has a $76 price target on shares.
• Hershey (HSY) and Sunoco (SUN) were upgraded to sell from conviction sell at Goldman.
• Level 3 Comm (LVLT) was upgraded to neutral from underweight at JPMorgan.
• Cathay Pacific (CPCAY) was upgraded to buy from hold at Deutsche Bank.

Analyst upgrades:

• Janney Montgomery upgraded Kenexa (NASDAQ: KNXA) and SuccessFactors (NASDAQ: SFSF) to Buy from Neutral on expectations corporate IT spending will accelerate in the second half of 2009. The firm raised its target on Kenexa to $14 from $8 and on SuccessFactors to $12 from $9.
• Jefferies upgraded PSS World Medical (NASDAQ: PSSI) to Buy from Hold to reflect the company's cost-cutting measures and efforts to gain market share. The firm raised its target on shares to $25 from $17.50.
• FBR Capital upgraded Sunpower (NASDAQ: SPWRA) to Outperform from Market Perform following the company's Q2 results to reflect increased business prospects in the "rooftop" segment of the market. FBR raised its target on shares to $40 from $22.
• Cooper Industries (NYSE: CBE) was upgraded to Outperform from Perform at Oppenheimer.
• Temple-Inland (NYSE: TIN) was upgraded to Buy from Neutral at UBS.
• Juniper Networks (NASDAQ: JNPR) was upgraded to Buy from Neutral at Goldman.

MOST NOTEWORTHY: Psychiatric Solutions, hhgregg and Ulta Salon were today's noteworthy initiations:

• Stanford started Psychiatric Solutions (NASDAQ: PSYS) with a Buy rating and $46 target and believes the recent pullback provides an attractive entry point given the company's stable growth and fundamentally strong business.
  
• Oppenheimer initiated hhgregg (NYSE: HGG) with a Perform rating. The firm believes the company's TV business could become much more challenging while housing market weakness could continue to hinder appliance sales.
• Oppenheimer also assumed Ulta Salon (NASDAQ: ULTA) with an Outperform rating and $13 target. The firm believes the company's fundamentals are solid and sees potential upside to valuation.

OTHER INITIATIONS:

• Piper initiated Ormat Tech (NYSE: ORA) with a Neutral rating and $49 target and Raser Technologies (NYSE: RZ) with a Sell rating and $7 target.
  
• The9 (NASDAQ: NCTY) was assumed at Roth Capital with a Hold rating and $27 target.
  
• Masimo (NASDAQ: MASI) was initiated with an Outperform rating and $44 target at BMO Capital.

MOST NOTEWORTHY: BioDelivery Sciences, Network Equipment, Barr Pharmaceuticals and Teva Pharmaceutical were today's noteworthy initiations:

• Merriman believes BioDelivery Sciences (NASDAQ:BDSI) is significantly undervalued given the positive results for BEMA Fentanyl and potential milestone payments of $60M, initiating shares with a Buy rating. They estimate fair value is in the $8-$10 range.
• Broadpoint believes Network Equipment (NYSE:NWK) is well-positioned for growth in the IP space, starting shares with a Buy rating.
• Banc of America started Barr Pharma (NYSE:BRL) with a Buy rating and $60 target, noting that the company's generic pipeline represents $30B in brand revenues and views Fosamax as the largest immediate opportunity. The firm also assumed coverage of Teva (NASDAQ:TEVA) with a Buy rating and $55 target, as they believe Teva's scale makes it the only generic company that can make a profit from aged generic products.

OTHER INITIATIONS:

• JP Morgan initiated Wintrust Financial (NASDAQ:WTFC) with a Neutral rating.
• Credit Suisse initiated Psychiatric Solutions (NASDAQ:PSYS) with an Underperform rating and $30 target.
• UBS started Weight Watchers (NYSE:WTW) with a Neutral rating and $51 target.

The Volunteer State is the home of Elvis Presley and the Grand Old Opry, former Vice President Al Gore, presidential candidate Fred Thompson, and the NFL's Tennessee Titans. Economically, Tennessee is the home of textiles, cotton, cattle, and electricity production, as well as mega corporations such as FedEx Corp. (NYSE: FDX) and International Paper Co. (NYSE: IP). And it is also the home of four companies from Fortune's 2007 list of the fastest growing public companies in the U.S.: Psychiatric Solutions Inc. (NASDAQ: PSYS), Pinnacle Financial Partners (NASDAQ: PNFP), Miller Industries Inc. (NYSE: MLR), and First Acceptance Corp. (NYSE: FAC).

At number 49 on Fortune's list was Psychiatric Solutions (PSI), the Franklin-based health care provider, which has grown in part through acquisitions. It has 900 psychiatric hospitals in 30 states, and operates in-patient facilities for other hospitals and government organizations. PSI's three-year revenue growth was 50%; three-year earnings per share growth at 76%. In July, PSI reported a record second quarter and a Lehman Brothers analyst expects PSI to meet or beat expectations in the current quarter. The consensus of analysts surveyed by Thomson Financial is that PSI is a buy, but Standard & Poor's is among those that consider PSI a strong buy. The share price was $39.90 on at the close on Friday.

Nashville-based Pinnacle Financial Partners is the holding company for Pinnacle National Bank, and holds assets of more than $2 billion. Pinnacle's three-year revenue growth was 81%, and its three-year earnings per share growth was 46%. Despite a strong second quarter report, the share price dropped to a 52-week low of $21.62 in August, but has bounced back since to $30.63 at the close on Friday. In September, a Pinnacle director bought 5,000 common shares of PNFP, and Pinnacle was among southern regional banks considered good bets despite the current credit climate. Analysts surveyed by Thomson Financial consider Pinnacle Financial a buy.